On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayMar 21, 2017 9:58 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Files Provisional Patent for Treatment of Eating Disorders Using Cannabis Extracts

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its filing of a provisional patent for the treatment of multiple types of eating disorders by a method and combination of cannabis extracts and other compounds. Should this filing result in the issuance of a patent, IGC intends to develop its IGC-506 candidate for both human and veterinary use. “The development of cannabis-based combination therapies represents a large, unique opportunity, and we believe we are the first mover in this emerging specialty-pharmaceutical sector,” Ram Mukunda, chief executive officer…

Continue Reading

ThursdayMar 16, 2017 12:35 pm

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article

India Globalization Capital (NYSE: IGC) was recently featured in an article detailing the company's strategic move to the cannabis industry and future plans for the company. In the past, IGC was a company primarily focused on the beneficiation of iron ore. That focus changed a few years ago when iron ore prices plummeted, often selling below its cost of production. For the last three years, the company has shifted its focus to tackling the cannabis industry, or more specifically, medical cannabis use. The company is currently developing a portfolio to address epilepsy, cachexia, PTSD, Alzheimer’s, and Parkinson’s. “We came up…

Continue Reading

ThursdayMar 16, 2017 10:40 am

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) Announces Engagement of CannabisNewsWire

Diversified holding company Player's Network, Inc. (OTCQB: PNTV) this morning announced its engagement of CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, CNW will look to generate greater brand awareness for Player’s Network as the company seeks to expand its presence in both the media and cannabis industries. “This partnership is an extension of our new shareholder…

Continue Reading

WednesdayMar 15, 2017 4:23 pm

CannabisNewsBreaks – Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth

As the medical marijuana market continues to grow, so does the number of biotech companies expanding their research into the development of innovative cannabinoid-based pharmaceuticals and delivery systems. It is estimated that the U.S. consumer market for cannabinoid pharmaceuticals will increase exponentially in upcoming years, exceeding $50 billion by 2029, according to Statista. This doesn’t appear to be a lofty forecast, given the prominence this market segment has gained by the sustained efforts and innovations of leading biotech companies such as InMed Pharmaceuticals, Inc. (IMLFF) (InMed Profile), GW Pharmaceuticals plc (GWPH), Zynerba Pharmaceuticals, Inc. (ZYNE), AXIM® Biotechnologies, Inc. (AXIM) and…

Continue Reading

WednesdayMar 15, 2017 4:21 pm

CannabisNewsBreaks – “No-Touch” Approach Reduces Risk as Public Companies Tap Explosive Growth of Cannabis Industry

The marijuana industry is the new investing frontier. As a result of last November’s elections, eight states and the District of Columbia now allow the recreational use of marijuana, while another 28 states permit its use for medicinal purposes. In what has been touted as the fastest-growing industry in the U.S., investment opportunities in the cannabis space appear boundless. Companies like Singlepoint, Inc. (SING) (SING Profile), American Cannabis Company Inc. (AMMJ), General Cannabis Corp. (CANN), The Scotts Miracle-Gro Company (SMG) and Terra Tech Corp. (TRTC) are all employing a “no-touch” approach to their cannabis business models. By creating business models…

Continue Reading

TuesdayMar 14, 2017 10:12 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Expands Presence in Cannabis Industry through Acquisition of Stake in Convectium

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has closed its first round of funding to acquire a stake in Jacksam Corp., dba Convectium, the developer of a unique oil filling system poised to revolutionize the cannabis industry. Originally announced at the end of January, the Convectium acquisition is expected to include an overall investment of stock and cash consideration totaling $800,000, which Convectium will use to help fund its growth as well as marketing of its revolutionary 710Shark and 710Seal system. Leaning on the marketability of the first-of-its-kind system, as well as its line of…

Continue Reading

FridayMar 10, 2017 10:25 am

CannabisNewsBreaks – Singlepoint, Inc. (SING) CEO Discusses Company’s Activity in the Cannabis Industry on MoneyTV

Full-service mobile technology and marketing provider Singlepoint, Inc. (OTC: SING) is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, Singlepoint CEO Greg Lambrecht discusses the company’s growing presence in the legal cannabis market. “While we’re waiting for the banks to open up, we’re finding other products that we can put in the dispensary. If you go to our SingleSeed.com site, you can see the stats specifically for dispensaries. So there’re really a…

Continue Reading

MondayMar 06, 2017 9:13 am

CannabisNewsBreaks – MyDx (MYDX) Makes Debut on HBO’s DAILY VICE News

Shares of MyDx (OTCQB: MYDX) closed Friday’s trade 23% higher after the company said its technology was featured on HBO's DAILY VICE News. MyDx is the developer of MyDx®, the first multi-use handheld chemical analyzer for consumers. The company has been concentrating on the development and market deployment of MyDx sensor technologies and accompanying applications as well as the expansion of its global sales footprint for the product line. The company is also working on creating a comprehensive database of physiologically relevant data from medical cannabis users. MyDx CEO Daniel Yazbeck will also be speaking at the 3rd Annual Cannabis…

Continue Reading

FridayMar 03, 2017 12:32 pm

CannabisNewsBreaks – Singlepoint, Inc. (SING) CEO Discusses M&A Strategy in Interview on MoneyTV

Full-service mobile technology and marketing provider Singlepoint, Inc. (OTC: SING) is as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, Singlepoint CEO Greg Lambrecht discusses the company’s recent activity, particularly as it relates to its expanded M&A strategy. “We’re really looking for companies in the cannabis business that do not touch the plant, for example a dispensary or grower like Convectium, who we have an LOI with,” Lambrecht noted in the interview.…

Continue Reading

FridayMar 03, 2017 11:21 am

CannabisNewsBreaks – NEMUS Bioscience, Inc. (NMUS), Catalent to Advance Development of NB1222 Human Dosage Formulation

NEMUS Bioscience (OTCQB: NMUS) this morning said it is moving forward with Catalent Pharma Solutions to advance development of a human-dosage suppository formulation of NB1222. NB1222 is the proprietary prodrug of tetrahydrocannabinol (THC) being developed for the treatment and management of chemotherapy-induced nausea and vomiting (CINV). NB1222, also known as the prodrug THC-valine-hemisuccinate, is synthetically manufactured and is not plant-derived. "The global CINV market is a multi-billion dollar opportunity with projected growth as populations live longer, increasing the likelihood of developing a malignancy over time," Nemus CEO and chief medical officer Brian Murphy, M.D. stated in the news release. To…

Continue Reading

Contact us: 303.498.7722